Individualizing patient treatment is a core objective of the medical field. Reaching this
objective has been elusive owing to the complex set of factors contributing to both disease …

The field of nanomedicine has made substantial strides in the areas of therapeutic and
diagnostic development. For example, nanoparticle-modified drug compounds and imaging …

Conventional therapeutic interventions, which range from drug treatment to learning and
training regimens, are often given at a fixed dose/intensity. This often leads to sub‐optimal …

Biopharmaceuticals and small-molecule drugs have different approval pathways but the
same quality control (QC) paradigm, where the quality of released but untested units is …

The integration of advanced computing tools, such as artificial neural networks and machine
learning, with genome sequencing has led to intriguing findings on individual or group …

There has not been a new treatment for Alzheimer's disease (AD) for over a decade, with a
large number of Phase II/III randomized clinical trials failing. Randomized clinical trials …

Rapid improvements in medical technology, big data analysis, and molecular medicine
come with promises of revolutionizing medical care. They span the spectrum from …